Edwards Lifesciences Corporation (EW) Stock Analysis
A live, multi-source view of Edwards Lifesciences Corporation (EW): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Sector: Healthcare · Industry: Medical Devices · United States · 16,000 employees · edwards.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Edwards Lifesciences Corporation (EW) had a market capitalization of $51.82B, a trailing P/E of 53.5 (forward 26.6) and a beta of 0.85; the shares traded in a 52-week range of $72.30 – $96.29 (11.9% over the year).
- Market cap
- $51.82B
- Enterprise value
- $48.38B
- Trailing P/E
- 53.5
- Forward P/E
- 26.6
- PEG ratio
- 1.94
- Price / book
- 4.88
- EPS (trailing)
- $1.68
- EPS (forward)
- $3.38
- Payout ratio
- 0.0%
- 52-week range
- $72.30 – $96.29
- 52-week change
- 11.9%
- Beta
- 0.85
- Average volume
- 4.2M
- Shares outstanding
- 576.4M
- Short % of float
- 2.02%
- Profit margin
- 15.4%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Edwards Lifesciences Corporation (EW) last closed at $86.77 (the last completed close before that scan).
Technicals at the scan: RSI 38 (neutral territory), price -3.7% versus its 20-day average, 20-day versus 50-day average spread +0.8%, MACD histogram -0.60.
Sentiment inputs: 100% of recent Finnhub-scored headlines read bullish; Reddit mentions +100% over 24 hours; analyst consensus score 72/100.
Next scheduled company event: in 48 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 1 buy and 0 sells of EW; corporate insiders filed 0 buys and 9 sells (7 distinct filers, latest disclosure 2026-08-31). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Wayne Markowitz (0B/3S), Daveen Chopra (0B/2S), Andrew M. Dahl (0B/1S), Annette Bruls (0B/1S), Daniel J. Lippis (0B/1S), Bernard J. Zovighian (0B/1S). Who is trading what
RapidTradeView pick record
EW has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Edwards Lifesciences Corporation (EW) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell EW.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.